CVS Health's turnaround efforts in focus amid record-high medical costs
CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...
Leerink lifts Inspire Medical stock target to $194, maintains rating
Leerink Partners made a slight adjustment to the price target of Inspire Medical Systems (NYSE:INSP), raising it from $193.00 to $194.00, while keeping a Market Perform rating on the stock. According ...